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chloroform method were subjected to a second 
application, this time by the silica method. 
The chloroform method eliminated the inhibitors 
from five, and the silica method from four, of nine 
sputa. The silica method was only beneficial in two 
samples that were still inhibitory after chloroform. 
However, these two samples had already been success- 
fully cleared of inhibitors by the silica method in the 
first round. Finally, inhibitors fi-om three sputa could be 
cleared only by the chloroform and two only by the 
silica method. Both methods were effective on two 
samples and neither on the remaining two. We con- 
cluded that the silica method, a more complex and 
multistep procedure, is not superior to the simple one- 
step chloroform method. Both methods are capable of 
eliminating inhibitors from different samples and so can 
be used one after the other for problem samples. 
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the diagnosis of C. dfiin'le-associated diarrhea is toxin 
detection. At least two different toxins can be 
produced: toxin A, primarily responsible for the 
enterotoxic activity which results in an inflammatory 
process and alteration of permeability, and toxin B, 
which has a direct cytopathic effect by depolymer- 
ization of filamentous actin, which causes destruction 
of the cell cytoskeleton [l]. The overwhelming majority 
of toxigenic strains produce both toxins, while neither 
of them is produced by non-toxigenic strains. 
Identification of toxigenic C. dficile has traditionally 
been performed by determining the cytopathic effect 
on cell cultures. This reliable assay indirectly detects C. 
dficile toxin B-producing strains. Nevertheless, the 
cytotoxic assay is time-consuming and it can produce 
up to 30% false-negative results in 'low producer' 
strains [l]. Several serologic tests have been used but 
none of them have been successful enough to replace 
the cytotoxic assay. Molecular biology techniques have 
also been developed for this purpose, including 
hybridization and PCR. Although some of these 
techniques have focused on the toxin B gene [2], most 
of them have targeted toxin A sequences [3]. The aim 
of this study was the development of a rapid test for the 
detection of the toxin B gene, which is always present 
in toxigenic strains, based upon a nested PCR. All the 
results have been compared with the cytotoxicity assay, 
which is the Dresent standard method. 
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Clostridiurn d@in'le is known to be the major cause 
of antibiotic-associated diarrhea and of pseudo- 
membranous colitis. An important requirement for 
Salmonella enterica, Aeromonas kydropkila and Campylo- 
bacter jejupi, were also included in order to study 
possible cross-reactions when assaying stool specimens 
directly. The toxigenicity of C. d@ile strains was 
evaluated by cell culture assay following standard 
procedures [4]. In cases in which direct toxin detection 
from stool samples was negative but a C. d f i l e  strain 
was isolated, monolayers were also inoculated with 
supernatant filtrates of C. dfiin'le pure broth cultures. 
Specificity of cytopathic effect was confirmed with a 
neutralizing high-titered antiserum (TechLab, VPI 
Research Park, Blacksburg, VA, USA). 
C. d@ile total DNA was extracted using a modi- 
fication of previously described methods [5]. The 
extraction protocol was carried out in anaerobic 
conditions until lysis was completed. A nested PCR 
was designed in order to achieve optimal sensitivity 
when direct samples were assayed. Primers were 
selected fi-om areas of the toxin B gene [6] where the 
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mole G+C percentage was slightly increased (G+C% 
of C. d e i l e  chromosome is 28%) in order to use 
relatively high annealing temperatures which allow 
specific amplification. Primers CDTB1, CDTB2 and 
CDTB3 (Table 1) were designed and checked for the 
absence of dimerization properties or internal loops by 
a specific software application. PCRs were carried out 
in 50 mL, containing 25 ng of total DNA (or 7 mL of 
the first amplification reaction), 2 mM MgC12, 5 pmol 
of each primer (CDTBl+CDTB3 for first reaction and 
CDTBl+CDTB2 for the second one), 200 mM each 
of dCTP, dGTP, dATP and dTTP (Boehringer 
Mannheim, Germany) and 0.5 U of Taq DNA poly- 
merase (Boehringer Mannheim, Germany), in Taq 
DNA polymerase incubation buffer. Amplifications 
were carried out in a thermal cycler (Perkin Elmer 
Cetus) for 30 cycles of 94"C/45 s ,  5OoC/45 s and 
72"C/75 s for the first amplification reaction, and 30 
cycles of 94 "C/45 s ,  55 "C/45 s and 72 "(230 s for the 
second reaction. Since nested PCR assays are known to 
be more apt to generate false-positive results than single 
PCR protocols, multiple negative controls, aerosol- 
resistant tips and separate processing areas were used to 
minimize the risk of amplicon contamination. After 
PCRs were completed, a volume of 10 to 15 mL 
was subjected to electrophoresis in 1.4% agarose gels 
followed by ethidium bromide staining. Sensitivity, 
specificity and predictive values were calculated for the 
designed PCR assay with reference to the cytotoxicity 
assay in accordance with previous descriptions [4]. 
The cytotoxic assay was positive with the 56 C. 
d f i k  isolates and the reference strain C. d@le ATCC 
9689. One of these, isolate no. 110, produced atypical 
cytopathic effects which remained after the addition of 
the specific antiserum. Four isolates were clearly non- 
toxigenic. 
Primers CDTB1-CDTB2 and CDTB1-CDTB3 
were used in a pilot assay study for the detection of the 
target sequence in single amplification reactions, but 
the results obtained were considerably less satisfactory 
than those produced by the nested reaction (data not 
shown). 
Table 1 Sequences, orientations and locations of PCR 
primers 
Primer Orientation Sequence (5'-3') Position 
CDTBl 3 GTGGCCCTGAAG 
CDTB2 e TCCTCTCTCTGAA 
CDTB3 e GCTTCTTCAATCC 
CATATG 1.804-1.821 
CTTCTTGC 2.106-2.126 
TTTCCTC 2.910-2.929 
322 bp - 
1 3 4 5 6 7 8 9 10 
Figure 1 Amplification patterns of the assayed isolates. 
Lanes 1 and 10, molecular weight markers; lane 2, 
amplification band corresponding to C. difile ATCC 
9689; lane 3, amplification of a non-toxigenic C. di@iZe 
clinical isolate (no. 9415) DNA lanes 4, 5 and 6, 
amplification of toxigenic C. d@le c h c a l  isolates 
(numbers 9430,9456 and 9490) DNAs (the hrst 
amplification product can also be seen in lane 6); lanes 7, 8 
and 9, amplification of C. sordellii, C. ramown and C. 
petjhgens DNAs respectively. 
Nested PCR assay showed the expected 322-bp 
amplification band corresponding to the Nested 
reaction (primers CDTB1-CDTB2). The band of 
1125 bp corresponding to the first amplification 
(primers CDTB1-CDTB3) was occasionally observed 
(Figure 1). PCR was positive for C. d @ d e  ATCC 9689 
and 54 clinical isolates of C. d@le, and negative for 
the remaining five isolates. Strain no. 110 (the one 
that produced atypical cytopathic effects) was PCR 
negative. All other assayed microorganisms, including 
other species of the genus, even C. sordellii, and the 20 
assayed enteropathogens, were both PCR negative and 
non-cytotoxic on cell cultures. Evaluation of the PCR 
assay in comparison with the present standard method, 
the cytotoxic assay, was as follows: sensitivity 100%; 
specificity 100%; positive predictive value 100%; 
negative predictive value 100%; false-negative rate 
0%; and false-positive rate 0%. Concordance between 
both techniques was absolute. 
As previously published, some low producer toxi- 
genic strains can go unnoticed if assayed on cell 
cultures. Furthermore, some strains, even when having 
a complete genetic composition for both toxins, fail to 
produce toxin B, which is the one detected on the 
cytotoxic assay [1,7]. On  the other hand, all non- 
toxigenic strains lack both toxin A and toxin B genes 
and most of the toxigenic strains have both genes. 
However, recently, some isolates have been encoun- 
tered which have the toxin B gene but lack the toxin 
A gene [8] ,  or in which the toxin A gene is incomplete 
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[9]. All of the above reasons led us to focus on the toxin 
B gene in order to detect all possible genetic situations 
in toxigenic strains. In contrast to some other published 
genetic methods based on hybridizations or single 
amplifications, we have designed a nested PCR which 
has allowed us to achieve 100% sensitivity. Specificity 
has been optimal, since no amplifications were detected, 
either on other species of Clostridium or in the entero- 
pathogens included in the study. In other published 
techniques, C. sordellii, whose toxin is highly homo- 
logous with the one produced by C. d @ d e  [l], has 
offered false-positive results by cross-reactions. In our 
case a positive amplification band has never been 
obtained within this microorganism. 
All strains included in this study were classified 
identically by both techniques, with the exception of 
strain no. 110, which was PCR negative and a toxin 
producer according to the cytotoxicity assay. Never- 
theless, its cytopathic effect on human fibroblasts is 
atypical and it was not inhibited by toxin B antitoxin, 
so it could have been the result of a cause unrelated to 
C. df ic i le  toxin B production. This finding still remains 
controversial; nevertheless, strain 110 was considered as 
non-cytotoxic and PCR negative when calculating 
sensitivities, predictive values, and false result rates. The 
1125-kb band corresponding to the first amplification 
reaction was occasionally seen. Probably, the amounts 
of this PCR product are at the limit of detection by 
agarose gel electrophoresis and so it is observed 
occasionally in cases where the reaction yield has been 
optimal. Usually in these cases the amount of the 
main amplification product (322-bp band) is slightly 
reduced, probably due to inhibition of the nested 
amplification reaction by an excess of DNA template 
in it [lo]. All our studied isolates of C. d@ale, with the 
exception of C. d@cile ATCC 9689, were isolated fiom 
significant clinical specimens. This may explain the 
high rate of toxigenicity encountered (over 93% of all 
C. df ic i le  clinical isolates included). 
Our approach for the detection of toxigenic strains 
of C. d@ale is easy both to perform and to interpret 
and offers excellent sensitivity and specificity. Some 
attempts have also been made on a reduced number of 
fecal specimens which showed adequate yields. Further 
studies are now ongoing. 
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Selection of rifampicin-resistant Mycobacferium 
fuberculosis does not occur in the presence of low 
concentrations of rifaximin 
C l i n  Microbiol Znfect 1997; 3: 147-151 
Rifaximin, an insoluble derivative of rifamycin-SV [l] 
that is very poorly absorbed fiom the gastrointestinal 
tract [2], has been proposed for the oral therapy of 
several bacterial enteric diseases [3-61. In fact, rifaximin 
is particularly efficacious in eradicating strains of 
Salmonella and Shigella spp. and Escherichia coli possess- 
ing different virulence factors [7]. Staphylococci, 
streptococci and other Gram-positive as well as Gram- 
negative, aerobic and anaerobic species are also 
inhibited by the compound [8-lo]. Mycobacteria 
are also killed in vitro, as would be expected of 
an antibiotic sharing the properties of the rifamycin 
Since rifampicin is widely used for treating tuber- 
culosis and other types of mycobacterial infections 
which are increasing worldwide [12], the aim of our 
family [ll]. 
